We look forward to seeing you at McCormick Place in Chicago
Because when your staff spends less time on manual work, they’re free to spend more time on human work.
Visit our ADLM 2025 home page to learn about the trends in clinical diagnostics that we will be talking about this year.
Exhibition Dates and Hours
Tuesday, July 29, 9:30 a.m. – 5:00 p.m. (CDT)
Wednesday, July 30, 9:30 a.m. – 5:00 p.m. (CDT)
Thursday, July 31, 9:30 a.m. – 12:00 p.m. (CDT)
We develop every assay in parallel with the analyzers that run them — from cardiac, oncology, thyroid, neurology, and infectious diseases — setting a new standard in assay performance while delivering superior workflow efficiency.
Join us Wednesday, July 30 in ADLM Theater 1 for two dynamic workshops led by top clinicians, laboratorians, and patients.
All posters will be presented in person during ADLM 2025 from 1:30 p.m. until 2:30 p.m. (CDT).
All Access registrants will be able to view ePosters from July 29 to August 29, 2025. Presented poster abstracts will be published as a supplement issue in ADLM's Clinical Chemistry.
POSTER # | POSTER TITLE | AUTHORS (presenter's name first) |
Cardiac | ||
A-001 | External Clinical Verification of the Atellica CI High-Sensitivity Troponin I Assay | Anthony Bonito, Navdeep K. Padda, Michael Anostario, Hairong Zhang, Ryan Butterfield |
A-019 | Clinical Laboratory Evaluation of the Analytical Performance of the Atellica IM NT-proBNPII (PBNPII) Assay on the Atellica CI Analyzer | Melanie Pollan, Joyce Melchior, Robert Burnett, JoDell E Wilson, Andrea Von Rotz |
A-024 | Prognosis for Adverse Events in Suspected ACS Without MI, and Subgroups with or Without History of Incident and Previous MACE Using the Atellica IM High-Sensitivity Troponin I Assay | Jennifer Snyder, Sarah Bethoney, Ryan Butterfield, Richard H Carter, Jr., Amy Tyler, Jingjing Zhang, Chadwick Brown, Jingjing Zhang, Kat Wong, Maria Pagano |
A-031 | Evaluation of the Analytical and Clinical Performance of the NT-proBNPII Assay on the Atellica CI Analyzer | B. Belth, Julia Warnock, Kelly Maher, Lynn Schiavoni, Navdeep Padda, Rachel Fonstad, Kalen Nissen, JoDell Wilson, Harry Liepold |
Data Analytics, Informatics, and Statistics | ||
B-138 | Assessing Pre-Analytical Error Prevalence and Associated Costs: Findings from a Multinational Survey and Literature Review | Artem T. Boltyenkov, Claudia A. Rhoades, Szu-Yu Kao, Kinpritma Sangha, Taras Dudykevych, Joshua Savina, Matthew J. Shashack, Vincent De Guire, Alexander von Meyer, Janne Cadamuro |
Drugs of Abuse | ||
B-280 | Performance Evaluation of the Emit II Plus Oxycodone, Buprenorphine, and 6-acetylmorphine Assays on the Atellica DT 250 System | Jessica Daughtry, Benjamin Israel, Heung Yeung (Harriet) Yau, Brandy Gwinn, Nihmat Morjana |
Endocrine POC | ||
A-414 | Assessment of the DCA Vantage and Atellica DCA HbA1c Dx Assays Compared to the European Reference Laboratory Method | Cassie Yost, Heidi Wagner, Nicole Ellis, Aaron Kauffmann, JoDell E. Wilson, and Jon Stradinger |
Engineering | ||
B-019 | A computational fluid dynamics simulation approach to designing the ATELLICA® CI Analyzer, focused on ensuring assay precision. | Chris Ebeling, Steffen Pharai, Michael Quintanilla, Jason Snyder (Chris Ebeling is attending) |
Infectious Disease | ||
A-260 | Analytical Performance Evaluation of the HIV Antigen/Antibody Combo Assay on the Atellica CI Analyzer | B. Belth, B. Healy, N. Riverso, G. Arrode-Bruses, H. Leipold |
A-261 | Evaluation of the Analytical Performance of the Total Antibodies to Hepatitis B Core Antigen Assay on the Atellica CI Analyzer | B. Belth, B. Healy, K. Maher, ,G. Arrode-Bruses, H. Leipold |
A-311 | Evaluation of the Analytical Performance of the Anti-Hepatitis B Surface Antigen assay on the Atellica CI Analyzer | M. Quintanilla, H. Zhang, G. Arrode-Bruses, H. Leipold |
A-312 | Evaluation of the Analytical Performance of the Hepatitis B Surface Antigen and confirmatory assays on the Atellica CI Analyzer | M. Quintanilla, A. Baldys, K. Thakur, G. Arrode-Bruses, H. Leipold |
A-313 | Analytical Performance Evaluation of the Hepatitis A Total Antibodies Assay on the Atellica CI Analyzer | M. Quintanilla, K. Brescia, J. Frenna, H. Zhang, G. Arrode-Bruses, H. Leipold |
Renal | ||
A-084 | Evaluation of the Analytical Performance Creatinine_3 Assay on the Atellica CH and CI Analyzers | Sandra Lewisch, Jennifer Cheek, Ravi Desai, Zach Eischeid, Victoria Shalhoub, Nicole Okeke |
Reproductive Endocrinology | ||
A-033 | Evaluation of the Analytical Performance of the Enhanced Estradiol Assay on the Atellica CI Analyzer | B. Belth, Nadia Riverso, Renee Aleo, JoDell E Wilson, Harry Leipold |
A-036 | Assessing the Analytical Performance of the Anti‑Müllerian Hormone Assay on the Atellica CI Analyzer | J. Bogdanovic, A. Baldys, K. Thakur, G. Arrode-Bruses, H. Leipold |
A-037 | Statistical Evaluation of the ADVIA Centaur Anti Müllerian Hormone Serological Assay for Predicting Poor Ovarian Response | Jelena Bogdanovic, Kaitlin Freeman, Geraldine Arrode-Bruses, Jennifer Snyder |
A-083 | Evaluation of the Analytical Performance of the Androstenedione Assay on the Atellica CI Analyzer | Sandra Lewisch, Michele Smith, JoDell E Wilson, Harry Leipold |
A-351 | Gestational Phase–Specific Cutoff Values for the Use of the (sFlt-1/ PlGF) Ratio as an Aid in Diagnosis for Preeclampsia | Sara Love, Andrea Wright, Nancy Carmosino, Sara Kastrup Shah, Sascha Lange, Maria Pagano, JoDell E Wilson, Agostino Palladino |
Sepsis | ||
A-321 | Performance evaluation of a rapid, universal and automation amenable sepsis diagnostic workflow that identifies pathogens and determines their antimicrobial resistance directly from whole blood | Ramya VM, Thomas A Hall, Divya S Khandige, Ishita Chakraborty, Lisa Risen, Christine Marzan, Michael Mosel, Jim Hannis, Megan Carpenter, Robert A. Bonomo, Rangarajan Sampath |
Thyroid | ||
A-032 | Evaluation of the Analytical Performance of Total Triiodothyronine (T3) and Total Thyroxine (T4) Assays on the Atellica CI Analyzer | B. Belth, Nadia Riverso, Brandon Czap, Victoria Shalhoub, Harry Leipold |
A-046 | Evaluation of the Clinical Performance of Anti Thyroid Peroxidase II and Anti Thyroglobulin II Assays on the ADVIA Centaur System | Kaitlin Freeman, Nazira Ozgen, Rana Fayyad, Kia Mardenborough, Jennifer Snyder |
A-047 | Evaluation of the Clinical Performance of the Thyroglobulin Assay on the Atellica IM Analyzer | Kaitlin Freeman, Nazira Ozgen, Lynn Schiavoni, Ryan Butterfield, Rachel Singleton, Jennifer Snyder |
A-067 | Evaluation of the Analytical Performance Anti Thyroid Peroxidase II Assay on the Atellica CI Analyzer | M. Quintanilla, Paul D’Agostino, Saji Cherian, Victoria Shalhoub, Harry Leipold |
B-052 | Evaluation of the Analytical Performance of the Thyroglobulin and Anti-Thyroglobulin II Assays on the Atellica CI Analyzer | M. Quintanilla, Badi Valdivia, Matt Coladangelo, Victoria Shalhoub, Harry Leipold |
ADLM is a busy place, and you deserve a break. And what better way to de-stress than making a furry friend. Visit the Puppy Zone in Booth #5442.
We’re always thinking about your lab — and your retriever, bulldog, and poodle, too!
After you’ve had a snuggle, stop by Booth #500 to learn how to make diagnostics feel like a walk in the park.
Venue Information
Location: Chicago, Illinois, USA
Venue: McCormick Place Convention Center (map)
(Convention center information)
Hosted by: The Association for Diagnostics & Laboratory Medicine (ADLM)
(formerly AACC, The American Association of Clinical Chemistry)